¿Dónde estamos ahora?

23 / 38

PARP inhibitors: Key Ongoing studies in PCa
1. ClinicalTrials.gov. NCT02975934. 2. ClinicalTrials.gov. NCT02987543. 3. ClinicalTrials.gov. NCT03012321.